Medigene AG maintained earnings guidance for 2024. For the year, company expects revenue to be between EUR 9 Million and 11 Million (unchanged) in 2024.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.303 EUR | +1.80% | +10.42% | -13.11% |
May. 21 | Medigene, BioNTech Extend Cancer Immunotherapy Partnership | MT |
May. 21 | Medigene AG's Global Research & Collaboration Agreement with BioNTech SE to Extend Beyond Initial Announced Term | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.11% | 41.06M | |
+19.11% | 125B | |
+13.88% | 108B | |
-4.51% | 24.57B | |
+3.32% | 22.82B | |
-10.49% | 18.19B | |
-41.48% | 16.54B | |
-11.95% | 16.5B | |
+3.02% | 13.39B | |
+26.38% | 11.1B |
- Stock Market
- Equities
- MDG1 Stock
- News Medigene AG
- Medigene Ag Maintains Earnings Guidance for 2024